PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $365,000 | +4.3% | 33,866 | +22.8% | 0.62% | +68.0% |
| Q2 2019 | $350,000 | -67.2% | 27,567 | +0.3% | 0.37% | -69.8% |
| Q1 2019 | $1,066,000 | -9.4% | 27,493 | +7.1% | 1.23% | +36.7% |
| Q3 2018 | $1,177,000 | -16.0% | 25,676 | +8.4% | 0.90% | -20.4% |
| Q2 2018 | $1,402,000 | -24.1% | 23,694 | -12.7% | 1.13% | -43.3% |
| Q1 2018 | $1,848,000 | -29.1% | 27,154 | +3.0% | 2.00% | -33.5% |
| Q4 2017 | $2,607,000 | +2.2% | 26,369 | +23.8% | 3.00% | +24.1% |
| Q3 2017 | $2,550,000 | -14.4% | 21,294 | -37.5% | 2.42% | -39.6% |
| Q2 2017 | $2,979,000 | +354.8% | 34,082 | +93.5% | 4.00% | +401.5% |
| Q1 2017 | $655,000 | +16.5% | 17,614 | -3.7% | 0.80% | +7.1% |
| Q4 2016 | $562,000 | -17.0% | 18,293 | -19.6% | 0.74% | -32.7% |
| Q2 2016 | $677,000 | – | 22,740 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |